However, Ely Lilly has developed an oral version of the medication, Orforglipron, that the pharmaceutical company plans to submit to the Food & Drug Administration for approval by the end of the year, and for type 2 diabetes treatment in 2026
This is a positive finding, as reflux can be a troublesome side effect for some patients and could otherwise undermine compliance
Well also discuss important considerations such as dose escalation, missed doses, side effects, and how this medication integrates with lifestyle changes for sustainable results
At New Results Medical Weight Loss, we help you achieve life-changing results with medically supervised weight loss programs tailored to your body and lifestyle
The Wegovy pill requires daily intake, while the injection is a weekly commitment, but both deliver semaglutide through the GLP-1 pathway